Capsugel said today that it expanded its late-stage inhalation formulation capabilities to move dry powder inhalation concepts through late-stage clinical trial and into commercial production. The company installed a new Harro Hofliger Modu-C MS encapsulation unit at its Oregon-based facility.
The machinery features specialized drum-dosing tech for use in dry powder inhalation development projects with spray-dry processing, Capsugel said.
Get the full story at our sister site, Drug Delivery Business News.
The post Capsugel expands into late-stage inhalation delivery appeared first on MassDevice.